Latest News and Press Releases

Déclarations de transparence parThe Goldman Sachs Group, Inc. Conformément à l'article 14, § 1 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Umicore a récemment été...

Transparantieverklaringen vanThe Goldman Sachs Group, Inc. In overeenstemming met artikel 14, § 1 van de wet van 2 mei 2007 betreffende de openbaarmaking van belangrijke deelnemingen, werd...

Transparency notification byJP Morgan Asset Management Holdings Inc. In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by...

Déclaration de transparence parJP Morgan Asset Management Holdings Inc. Conformément à l'article 14, § 1 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Umicore a...

Transparantieverklaring vanJP Morgan Asset Management Holdings Inc. In overeenstemming met artikel 14, § 1 van de wet van 2 mei 2007 betreffende de openbaarmaking van belangrijke deelnemingen,...

Please find below Aedifica’s interim financial report for the 1st quarter of the 2026 financial year. Creating Europe’s leading healthcare REIT Aedifica acquired control over Cofinimmo on 10 March...

BEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; “we” or the “Company”), today announced that it will effect a reverse share split of its outstanding Class A...

Base shelf prospectus is accessible, and prospectus supplement will be accessible within two business days on SEDAR+1 TORONTO and HOUSTON, May 19, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics...

WALTHAM, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the...

WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science,...